Strengers, P. F. (2023). Challenges for Plasma-Derived Medicinal Products. Transfusion medicine and hemotherapy, 50(2), 116-122. https://doi.org/10.1159/000528959
Chicago Style (17th ed.) CitationStrengers, Paul F.W. "Challenges for Plasma-Derived Medicinal Products." Transfusion Medicine and Hemotherapy 50, no. 2 (2023): 116-122. https://doi.org/10.1159/000528959.
MLA (9th ed.) CitationStrengers, Paul F.W. "Challenges for Plasma-Derived Medicinal Products." Transfusion Medicine and Hemotherapy, vol. 50, no. 2, 2023, pp. 116-122, https://doi.org/10.1159/000528959.
Warning: These citations may not always be 100% accurate.